Clinical Trials in Nagoya, Aichi

Find clinical trials in Nagoya, Aichi. Discover local research opportunities and treatment options in your area.

105 Active Trials Found in Nagoya

Showing 105 trials on this page

Page 1 of 6

A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))

NCT ID: NCT05731128

This clinical trial, called LIBERTY-UC SUCCEED, is investigating the effectiveness and safety of a medication called dupilumab for adults aged 18 and older who have moderately to severely active ul...

Recruiting

Phase: PHASE2 Conditions: Colitis Ulcerative

A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

NCT ID: NCT06311721

This clinical trial is studying a new treatment called ABP 234 and comparing it to an existing medication known as Keytruda® (pembrolizumab) for patients with advanced non-squamous non-small cell l...

Recruiting

Phase: PHASE3 Conditions: Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

Specified Drug-use Surveillance of Fabhalta Capsules

NCT ID: NCT06606314

This clinical trial is studying Fabhalta capsules, a treatment for a rare blood condition called Paroxysmal Nocturnal Hemoglobinuria (PNH). The trial is designed to gather information about how wel...

Recruiting

Conditions: Paroxysmal Nocturnal Hemoglobinuria

Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)

NCT ID: NCT06073821

This clinical trial is studying the effectiveness of two different treatment combinations for people with chronic lymphocytic leukemia (CLL), a type of cancer that affects the blood and bone marrow...

Recruiting

Phase: PHASE3 Conditions: CLL

A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

NCT ID: NCT06468228

This clinical trial is studying a new drug called lutikizumab to see how well it works and how safe it is for treating moderate to severe hidradenitis suppurativa (HS), a painful skin condition tha...

Recruiting

Phase: PHASE3 Conditions: Hidradenitis Suppurativa

A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

NCT ID: NCT06846671

This clinical trial is studying a new treatment called BGB-16673 for patients with chronic lymphocytic leukemia (CLL) who have already received certain other treatments. The goal is to see how effe...

Recruiting

Phase: PHASE3 Conditions: Chronic Lymphocytic Leukemia, CLL

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

NCT ID: NCT05020236

The MagnetisMM-5 clinical trial is studying a new treatment option for people with relapsed or refractory multiple myeloma, a type of blood cancer. Researchers want to see if a medication called el...

Recruiting

Phase: PHASE3 Conditions: Multiple Myeloma

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

NCT ID: NCT05317416

This clinical trial is studying a new treatment called elranatamab to see if it is more effective than a standard treatment called lenalidomide for patients with newly diagnosed multiple myeloma wh...

Recruiting

Phase: PHASE3 Conditions: Multiple Myeloma

A Study of ASP3082 in Adults With Advanced Solid Tumors

NCT ID: NCT05382559

This clinical trial is studying a new treatment called ASP3082 for adults with specific types of cancer known as solid tumors, particularly those with a mutation in a gene called KRAS (specifically...

Recruiting

Phase: PHASE1 Conditions: Solid Tumor

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

NCT ID: NCT06152575

The MagnetisMM-32 clinical trial is studying a new medicine called elranatamab for people with multiple myeloma (MM), a type of blood cancer that has returned after previous treatments. The trial a...

Recruiting

Phase: PHASE3 Conditions: Multiple Myeloma

Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

NCT ID: NCT06132958

This clinical trial is studying a new treatment called MK-2870, also known as sacituzumab tirumotecan, for women with endometrial cancer who have already received certain types of treatments. These...

Recruiting

Phase: PHASE3 Conditions: Endometrial Cancer

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

NCT ID: NCT06158841

This clinical trial is studying a new treatment called ABBV-383 for adults with relapsed or refractory multiple myeloma, which is a type of blood cancer that affects plasma cells. The trial will co...

Recruiting

Phase: PHASE3 Conditions: Multiple Myeloma

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

NCT ID: NCT06312176

This clinical trial is studying a new treatment option for patients with a specific type of breast cancer called hormone receptor positive and HER2 negative (HR+/HER2-). The researchers want to see...

Recruiting

Phase: PHASE3 Conditions: Breast Neoplasms

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

NCT ID: NCT06717347

This clinical trial is studying a new treatment for patients with diffuse large B-cell lymphoma (DLBCL), a type of cancer that affects the lymphatic system. Researchers want to see if adding a drug...

Recruiting

Phase: PHASE3 Conditions: Diffuse Large B-Cell Lymphoma

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

NCT ID: NCT06841354

This clinical trial is studying the effectiveness of a drug called sacituzumab tirumotecan (also known as Sac-TMT) both on its own and in combination with another drug called pembrolizumab for trea...

Recruiting

Phase: PHASE3 Conditions: Triple Negative Breast Neoplasms

A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

NCT ID: NCT06953960

This clinical trial is studying a new medication called ABBV-453 for adults with multiple myeloma (MM), a type of cancer affecting the bone marrow. The trial aims to find out how safe ABBV-453 is a...

Recruiting

Phase: PHASE1 Conditions: Multiple Myeloma

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

NCT ID: NCT03486873

This clinical trial, called MK-3475-587, is looking into the long-term safety and effectiveness of a treatment called pembrolizumab (also known as MK-3475) for patients with advanced tumors. If you...

Recruiting

Phase: PHASE3 Conditions: Solid Tumors, Hematologic Malignancies

Pan Tumor Rollover Study

NCT ID: NCT03899155

The Pan Tumor Rollover Study is a clinical trial focused on understanding the long-term safety of a cancer treatment called nivolumab, both on its own and in combination with other therapies. This ...

Recruiting

Phase: PHASE2 Conditions: Cancer

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

NCT ID: NCT04464226

This clinical trial is studying the continuation of a treatment called darolutamide for men with cancer who have already participated in previous studies using this medication. The goal is to provi...

Recruiting

Phase: PHASE3 Conditions: Cancer

A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

NCT ID: NCT05552976

The SUCCESSOR-2 trial is studying a new treatment for patients with relapsed or refractory multiple myeloma, a type of blood cancer. This trial is comparing a combination of three medications: Mezi...

Recruiting

Phase: PHASE3 Conditions: Relapsed or Refractory Multiple Myeloma